NCT05212467

Brief Summary

This study will compare an Amygdala and insula retraining (AIR) program to an internet therapy developed at Helsinki University Hospital. The study will be a multi-center randomized controlled trial. Study units will be recruited from the Network for Functional Disorders that is hosted by the HUS Clinic for Functional Disorders and potentially later from international collaborators. The trial will clarify whether internet-based non-drug based therapies are helpful in overcoming the central sensitization and the functional disabilities caused by these disorders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

January 31, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 10, 2022

Status Verified

January 1, 2022

Enrollment Period

1.9 years

First QC Date

January 24, 2022

Last Update Submit

January 27, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in functional ability as measured by the WHODAS2.0 instrument at six months.

    3, 6 and 12 months

Secondary Outcomes (7)

  • Change from baseline in quality of life as measured by EUROHIS-8

    3, 6 and 12 months

  • Change from baseline in health related quality of life as measured by 15D

    3, 6 and 12 months

  • Change from baseline in symptoms as measured by SSD-12 and PHQ-15

    3, 6 and 12 months

  • Change from baseline in depression as measured by PHQ-9

    3, 6 and 12 months

  • Change from baseline in anxiety as measured by GAD-7

    3, 6 and 12 months

  • +2 more secondary outcomes

Study Arms (3)

AIR-program

ACTIVE COMPARATOR

• The Amygdala and insula retraining program consists of novel brain retraining approaches focused on hypothetically interrupting and retraining the conditioned defensive hyper-stimulation of the sympathetic nervous system and aspects of the immune system by the amygdala and insula, to bring the brain and body back to homeostasis. It includes supportive techniques such as breathing, meditation, and neurolinguistic programming. The patients are invited to an online program of video session and eight weekly 2 h webinar sessions followed by three monthly sessions. The patients are assigned to do daily homework that takes approximately 15 to 20 min to complete

Behavioral: AIR-programBehavioral: Treatment as usual

HUS Internet therapy

ACTIVE COMPARATOR

The HUS internet therapy for bodily stress syndromes (iHUSbss) includes psychoeducation about autonomic nervous system and of the effects of patient's own thinking and action on the nervous system. The exercises aim at relaxing the body, at novel ways to observe the symptoms, and at developing acceptance and self-compassion. The program includes exercises that are done regularly in everyday life.

Behavioral: HUS Internet therapyBehavioral: Treatment as usual

Treatment as usual

PLACEBO COMPARATOR

The patients may have appointments with their physician, physiotherapist, or another health professional, and they may attend group interventions. If possible, medication is kept the same during the intervention and three months afterwards. If there is need to change the medication during the trial, the changes will be recorded. Appointments with health professionals and attendance in group interventions are monitored.

Behavioral: Treatment as usual

Interventions

AIR-programBEHAVIORAL

This is a guided self management program that is added on the treatment as usual.

AIR-program

This is a guided self management program that is added on the treatment as usual.

HUS Internet therapy

The patients receive routine care from their physician which may include drugs, visits or rehabilitation

AIR-programHUS Internet therapyTreatment as usual

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The criteria of bodily stress syndrome, fibromyalgia, chronic fatigue syndrome, or long Covid fulfilled AND
  • Diagnostic examinations have ruled out the potential somatic reasons for the symptoms AND
  • Disabling symptoms have lasted at least 3 months AND
  • Patient is willing to receive a psychoeducation or brain retraining intervention.

You may not qualify if:

  • Patients for whom participation could be overly demanding because of physical constraints (for example, patients who cannot write because of dystonia or bedridden patients)
  • Patients with presence of severe psychiatric and severe somatic disorders, e.g. moderate or severe depression or newly onset cancer for which the study could be overly strenuous.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinic for Functional Disorders, HUS

Helsinki, 00029, Finland

RECRUITING

Clinic for Long Covid, HUS

Helsinki, 00029, Finland

RECRUITING

Related Publications (1)

  • Vangelova-Korpinen V, Liira H, Kurki SN, Sainio M, Malmivaara A, Kanerva M, Stenberg JH, Varonen M, Venalainen M, Vuorela P, Arokoski J. Effectiveness of mindfulness-based online therapy or internet-delivered cognitive behavioral therapy compared with treatment as usual among patients with persistent somatic symptoms: Protocol for a randomized controlled trial. PLoS One. 2025 Feb 12;20(2):e0316169. doi: 10.1371/journal.pone.0316169. eCollection 2025.

MeSH Terms

Interventions

Therapeutics

Central Study Contacts

Helena Liira, MD, PhD

CONTACT

Jari Arokoski, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients are randomized to one of the three treatment groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

January 24, 2022

First Posted

January 28, 2022

Study Start

January 31, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

February 10, 2022

Record last verified: 2022-01

Locations